Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Journal of Korean Neurosurgical Society

Volumn 52, Issue 2, 2012, Pages 75-79

  Jeon, Jin Sue ^a   Sheen, Seung Hun ^a   Hwang, Gyojun ^a   Kang, Suk Hyung ^a   Heo, Dong Hwa ^a   Cho, Yong Jun ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

Cerebral vasospasm; Magnesium sulfate; Subarachnoid hemorrhage

Indexed keywords

MAGNESIUM; NIMODIPINE;

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN VASOSPASM; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; KOREA; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; RANKIN SCALE; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

EID: 84867035448     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2012.52.2.75     Document Type: Article

References (24)

1. Altura BT, Altura BM: Interactions of Mg and K on cerebral vessels-aspects in view of stroke. Review of present status and new findings. Magnesium 3: 195-211, 1984
2. Barbarawi M, Smith SF, Jamous MA, Haboub H, Suhair Q, Abdullah S: Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysm. Neurol Int 1: e13, 2009
3. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, et al.: Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 25: 1067-1076, 2004
4. Boet R, Mee E: Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 47: 602-606; discussion 606-607, 2000
5. Collignon FP, Friedman JA, Piepgras DG, Pichelmann MA, McIver JI, Toussaint LG 3rd, et al.: Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care 1: 441-448, 2004
6. Friedlich D, Agner C, Boulos AS, Mesfin F, Feustel P, Bernardini GL, et al.: Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm: a single center experience. Neurol Res 31: 621-625, 2009
7. Keyrouz SG, Diringer MN: Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 11: 220, 2007
8. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R: Magnesium and experimental vasospasm. J Neurosurg 100: 106-110, 2004
9. Mori K, Yamamoto T, Miyazaki M, Hara Y, Aiko Y, Koike N, et al.: Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. J Neurosurg 114: 1168-1175, 2011
10. Mori K, Yamamoto T, Nakao Y, Osada H, Hara Y, Oyama K, et al.: Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 49: 139-144; discussion 144-145, 2009
11. Muir KW, Lees KR, Ford I, Davis S: Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363: 439-445, 2004
12. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, et al.: Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 92: 284-290, 2000
13. Rubin DB, Thomas N: Combining propensity score matching with additional adjustments for prognostic covariates. J Am Stat Assoc 95: 573-585, 2000
14. Sang N, Meng Z: Blockade by magnesium of sodium currents in acutely isolated hippocampal CA1 neurons of rat. Brain Res 952: 218-221, 2002
15. Satoh A, Sugiyama T, Ooigawa H, Nakajima H, Ogura T, Neki H, et al.: Prevention of symptomatic vasospasm by continuous cisternal irrigation with mock-CSF containing ascorbic acid and Mg(2+). Acta Neurochir Suppl 107: 115-118, 2010
16. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ: Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien) 145: 195-199; discussion 199, 2003
17. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ: Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 52: 276-281; discussion 281-282, 2003
18. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al.: Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36: 1011-1015, 2005
19. van den Bergh WM, Dijkhuizen RM, Rinkel GJ: Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 17: 301-313, 2004
20. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, et al.: Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96: 510-514, 2002
21. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, et al.: Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med 38: 1284-1290, 2010
22. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al.: Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 41: 921-926, 2010
23. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al.: Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial. Stroke 41: 1841-1844, 2010
24. Yahia AM, Kirmani JF, Qureshi AI, Guterman LR, Hopkins LN: The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care 3: 16-23, 2005